DVA - DaVita Inc.

Boasting A 30% Return On Equity, Is DaVita Inc. (NYSE:DVA) A Top Quality Stock?

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Here's Why You Should Retain DaVita (DVA) Stock for Now

Investors remain optimistic about DaVita (DVA) due to the strength of its DaVita Kidney Care.

• 
  New Strong Sell Stocks for June 5th

  Zacks
• 
  Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

  Zacks

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

• 
  Here's Why Gap (GPS) is a Strong Value Stock

  Zacks
• 
  Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

  Zacks

Medtronic (MDT) to Expand Diabetes Care With New Buyout

Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.

• 
  Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

  Zacks
• 
  Hologic (HOLX) Stock Up 5.6% YTD: Will the Rally Continue?

  Zacks

Thermo Fisher (TMO) Expands Manufacturing Facility in APAC

Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.

Here's Why Investors Should Add Zimmer Biomet (ZBH) Now

Investors are optimistic about Zimmer Biomet (ZBH) on continued procedure recovery, solid execution and increasing traction around innovations.

• 
  Here's Why Investors Should Buy Allegiant (ALGT) Stock Now

  Zacks
• 
  New Strong Sell Stocks for June 5th

  Zacks

QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory

QIAGEN is a one-stop shop for all research needs, including solutions for sample preparation, automation and bioinformatics with enzyme offering expansion.

National Vision (EYE) Plans to Open New Stores Amid Macro Woes

National Vision (EYE) plans to continue executing core growth initiatives and further investing in competitive advantages.

Abbott (ABT) Expands in Electrophysiology With New FDA Nod

Abbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters.

Hologic (HOLX) Gets FDA Nod for Multiplexed Respiratory Test

Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.

Abbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA Approval

Abbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively.

What's in the Cards for Medtronic (MDT) in Q4 Earnings?

Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.

STERIS (STE) Continues to Face Dull Dental Sales, Margin Woes

STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.

Veeva Systems' (VEEV) New Launch to Improve Patient Outcomes

Veeva Systems' (VEEV) new offering is expected to facilitate effective engagement with customers and KOLs for improved patient journeys.

Edwards Lifesciences' (EW) TAVR Study Outcome Favorable

Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing.

• 
  New Strong Sell Stocks for June 5th

  Zacks
• 
  Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

  Zacks

BD's (BDX) New FDA Approval to Improve MRSA Diagnostics

BD's (BDX) receipt of the latest FDA approval is likely to improve laboratory workflow.

Medtronic's (MDT) Global Market Share Strong, FX Headwind Stays

Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.

LabCorp (LH) Expands Laboratory Relationship With New Pact

LabCorp's (LH) recent partnership will expand healthcare access, offer advanced diagnostic tools and guarantee that both patients and doctors can afford the treatments they get.

NextGen (NXGN) Q4 Earnings Top Estimates, Revenues Surge Y/Y

NextGen's (NXGN) fourth-quarter fiscal 2023 results reflect strength in both its revenue sources.

3 Reasons to Retain Masimo (MASI) Stock in Your Portfolio

Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.

• 
  Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now

  Zacks
• 
  New Strong Sell Stocks for June 5th

  Zacks

DaVita Inc.'s (NYSE:DVA) Intrinsic Value Is Potentially 50% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, DaVita fair value estimate is US$148 DaVita is estimated to be...

Shockwave Medical (SWAV) Launches IVL Catheter in Select Markets

Shockwave Medical's (SWAV) latest commercial availability and the patient enrollment in its study are expected to serve a wider patient pool.